tiprankstipranks
Trending News
More News >
4D Molecular Therapeutics (FDMT)
NASDAQ:FDMT
US Market
Advertisement

4D Molecular Therapeutics (FDMT) Financial Statements

Compare
438 Followers

4D Molecular Therapeutics Financial Overview

4D Molecular Therapeutics's market cap is currently $391.83M. The company's EPS TTM is $-0.98; its P/E ratio is ―; 4D Molecular Therapeutics is scheduled to report earnings on August 11, 2025, and the estimated EPS forecast is $-0.98. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Currency in USD

4D Molecular Therapeutics Earnings and Revenue History

4D Molecular Therapeutics Debt to Assets

4D Molecular Therapeutics Cash Flow

4D Molecular Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis